Aprepitant and fosaprepitant drug interactions: a systematic review-Reference-Cited by-同舟云学术

Aprepitant and fosaprepitant drug interactions: a systematic review

Published:2017-06-10 Issue:10 Volume:83 Page:2148-2162
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Patel Priya¹²^ORCID,Leeder J. Steven³⁴,Piquette-Miller Micheline¹,Dupuis L. Lee¹²⁵

Affiliation:

1. Leslie Dan Faculty of Pharmacy; University of Toronto; Toronto Ontario Canada

2. Department of Pharmacy; The Hospital for Sick Children; Toronto Ontario Canada

3. Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Department of Pediatrics; Children's Mercy-Kansas City; Kansas City Missouri USA

4. School of Medicine; University of Missouri-Kansas City; Kansas City Missouri USA

5. Child Health Evaluative Sciences, Research Institute; The Hospital for Sick Children; Toronto Ontario Canada

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13322/fullpdf

Reference85 articles.

1. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands;Southan;Nucl Acids Res,2016

2. The Concise Guide to PHARMACOLOGY 2015/16: G protein coupled receptors;Alexander;Br J Pharmacol,2015

3. The Concise Guide to PHARMACOLOGY 2015/16: Enzymes;Alexander;Br J Pharmacol,2015

4. Antiemetics: American Society of Clinical Oncology clinical practice guideline update;Basch;J Clin Oncol,2011

5. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference;Roila;Ann Oncol,2010

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the impact of aprepitant on response to dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP);Journal of Oncology Pharmacy Practice;2024-08-07

2. Evaluation of Efficacy of Adding Aprepitant to Palonosetron and Dexamethasone in Carboplatin and Etoposide Therapy;Biological and Pharmaceutical Bulletin;2024-06-19

3. Mirtazapine plus granisetron and dexamethasone for carboplatin-induced nausea and vomiting in patients with thoracic cancers: A prospective multicenter phase II trial;Lung Cancer;2024-06

4. Anti-Emetics in Children Receiving Chemotherapy for Solid Tumors and Leukemia: Pharmacology and Optimization of Therapy for Nausea and Vomiting;Pharmaceuticals;2024-05-10

5. Mechanism Underlying Conflicting Drug-Drug Interaction Between Aprepitant and Voriconazole via Cytochrome P450 3A4-Mediated Metabolism;Yonago Acta Medica;2024